This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Zynex faces class action lawsuit
Business class action

Zynex faces class action lawsuit

Analysis based on 12 articles · First reported Mar 26, 2025 · Last updated Apr 07, 2025

Sentiment
-50
Attention
2
Articles
12
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the potential financial penalties and reputational damage to Zynex, which could lead to a decline in its stock price. Investors who purchased Zynex shares during the class period may seek recovery through the class action lawsuit initiated by The Gross Law Firm.

Medical devices Legal services
Event Summary

Zynex, a publicly traded company, is facing a class action lawsuit initiated by The Gross Law Firm on behalf of its shareholders. The lawsuit alleges that Zynex engaged in practices such as shipping products in excess of need and filing false claims, which led to inflated revenue. These practices drew scrutiny from insurers, including United States — Tricare, the U.S. military health insurance program. The complaint suggests that Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government of the United States. The class period for the lawsuit is from March 13, 2023, to March 11, 2025, with a deadline for lead plaintiff appointment set for May 19, 2025.

Key Actions
90 Zynex shipped products in excess
90 Zynex filed false claims United States — Tricare
Entities Involved
stock
Zynex
Zynex is facing a class action lawsuit for allegedly inflating revenue by shipping products in excess of need and filing false claims, which could lead to removal from insurer networks and government penalties.
Importance 100.0 Sentiment -70.0
govactor
United States — Tricare
United States — Tricare, the U.S. military health insurance program, is one of the insurers that scrutinized Zynex's practice of filing false claims.
Importance 40.0 Sentiment 0.0
cnt
United States
Importance 0.0 Sentiment 0.0
Relationships
Zynex investigated provider ↔ United States — Tricare Zynex is a medical device provider that bills the US government's Tricare program. The relationship is currently adversa
United States — Tricare related ↔ United States
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.